NCT05872282

Percutaneous Endovascular Arch Repair Trial (PEART) Study

Feasible Study on a New Technique of ZIPPER Aortic Arch Stentgraft System in the Treatment of Aortic Arch Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Hangzhou Endonom Medtech Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system

Detailed description

The feasible study of ZIPPER aortic arch stentgraft system is a prospective, multicenter, single arm trial, which will enroll a total of 24 patients. The goal of this study is to evaluate the safety and efficacy of ZIPPER aortic arch stentgraft system in the treatment of patients with aortic arch disease, included aortic arch dissections, aneurysms, residual dissection following ascending aorta surgical operation.

Conditions

• Aortic Diseases

Interventions

Type	Name	Description
DEVICE	ZIPPER aortic arch stentgraft system	The ZIPPER aortic arch stentgraft system consists of the arch mainbody stentgraft system, the branch artery stentgraft system and the thoracic extension stentgraft system.

Timeline

• Start date: 2023-04-28
• Primary completion: 2025-04-28
• Completion: 2025-04-28
• First posted: 2023-05-24
• Last updated: 2024-01-02

Locations

3 sites across 1 country: China